Alexion Pharmaceuticals stock price target cut to $205 from $220 at Barclays Related posts: Economic Report: Draghi’s statement at the June ECB meeting in full IMF chief: Loss of small-country banking access risks ‘systemic’ disruptions RPT-UPDATE 1-Former Dutch finance minister Zalm to resign as ABN Amro CEO New York seeks $872 mln from UPS in cigarette shipments trial Post navigation Alexion Pharmaceuticals downgraded to equal weight from overweight at Barclays Vertex Pharmaceuticals stock price target raised to $150 from $120 at Barclays
